Dr. Sandborn directs a large clinical research unit devoted to the conducting clinical trials in inflammatory bowel disease, where he supervises a multi-investigator team of physicians, research fellows, nurses and study coordinators. He is internationally recognized for his contributions in the fields of biotechnology therapy, clinical pharmacology, diagnosis and treatment of pouchitis, epidemiology and natural history and endoscopic and radiographic imaging techniques.
Dr. Sandborn has published more than 408 articles, including articles in the New England Journal of Medicine, The Lancet, JAMA, Annals of Internal Medicine and Gastroenterology.
Dr. Sandborn earned his medical degree from Loma Linda (Calif.) University and completed his residency at Loma Linda (Calif.) Medical Center. He also completed a fellowship in gastroenterology at the Mayo Clinic in Rochester, Minn.
More articles on GI & endoscopy:
Mederi Therapeutics launches 3rd generation of Stretta, Boston Scientific reports Q1 2016 financials & more — 5 GI company key notes
Gastroenterologist pay in the US, UK, Canada & Australia: 5 notes
Seres Therapeutics signs research agreements to support development of microbiome therapy for IBD: 3 points
